vs
Aclarion, Inc.（ACON）与RadNet, Inc.（RDNT）财务数据对比。点击上方公司名可切换其他公司
RadNet, Inc.的季度营收约是Aclarion, Inc.的29641.3倍（$547.7M vs $18.5K）。RadNet, Inc.净利率更高（-0.1% vs -10223.7%，领先10223.6%）。Aclarion, Inc.同比增速更快（80.6% vs 14.8%）。过去两年Aclarion, Inc.的营收复合增速更高（35.2% vs 12.6%）
Aclarion, Inc.是一家专注于慢性下背痛诊疗的医疗科技企业，核心产品基于专利磁共振波谱技术，可精准识别患者的疼痛性椎间盘，服务美国市场的医疗机构与患者，业务覆盖慢性疼痛管理、脊柱护理两大核心领域。
RadNet是美国领先的放射医疗服务企业，总部位于加利福尼亚州洛杉矶，是美国规模最大的独立固定地址诊断影像中心运营商，按网点数量及年度影像业务收入计均居行业首位。截至2025年，该公司在全美8个州持有或运营超400家影像中心，提供门诊诊断影像服务。
ACON vs RDNT — 直观对比
营收规模更大
RDNT
是对方的29641.3倍
$18.5K
营收增速更快
ACON
高出65.8%
14.8%
净利率更高
RDNT
高出10223.6%
-10223.7%
两年增速更快
ACON
近两年复合增速
12.6%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $18.5K | $547.7M |
| 净利润 | $-1.9M | $-597.0K |
| 毛利率 | 9.7% | — |
| 营业利润率 | -10785.8% | 5.1% |
| 净利率 | -10223.7% | -0.1% |
| 营收同比 | 80.6% | 14.8% |
| 净利润同比 | 5.0% | -111.2% |
| 每股收益（稀释后） | $1.39 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ACONRDNT
| Q4 25 | $18.5K | $547.7M | ||
| Q3 25 | $18.9K | $522.9M | ||
| Q2 25 | $19.3K | $498.2M | ||
| Q1 25 | $19.0K | $471.4M | ||
| Q4 24 | $10.2K | $477.1M | ||
| Q3 24 | $14.4K | $461.1M | ||
| Q2 24 | $11.0K | $459.7M | ||
| Q1 24 | $10.1K | $431.7M |
净利润ACONRDNT
| Q4 25 | $-1.9M | $-597.0K | ||
| Q3 25 | $-1.7M | $5.4M | ||
| Q2 25 | $-1.6M | $14.5M | ||
| Q1 25 | $-2.0M | $-37.9M | ||
| Q4 24 | $-2.0M | $5.3M | ||
| Q3 24 | $-1.4M | $3.2M | ||
| Q2 24 | $-1.2M | $-3.0M | ||
| Q1 24 | $-2.4M | $-2.8M |
毛利率ACONRDNT
| Q4 25 | 9.7% | — | ||
| Q3 25 | 23.2% | — | ||
| Q2 25 | 26.6% | — | ||
| Q1 25 | -23.6% | — | ||
| Q4 24 | -100.9% | — | ||
| Q3 24 | -48.1% | — | ||
| Q2 24 | -112.3% | — | ||
| Q1 24 | -92.6% | — |
营业利润率ACONRDNT
| Q4 25 | -10785.8% | 5.1% | ||
| Q3 25 | -9666.2% | 5.2% | ||
| Q2 25 | -8988.6% | 6.2% | ||
| Q1 25 | -7856.0% | -5.1% | ||
| Q4 24 | -17652.7% | 5.1% | ||
| Q3 24 | -8995.3% | 7.4% | ||
| Q2 24 | -10350.6% | 7.6% | ||
| Q1 24 | -12609.3% | 2.6% |
净利率ACONRDNT
| Q4 25 | -10223.7% | -0.1% | ||
| Q3 25 | -9008.0% | 1.0% | ||
| Q2 25 | -8285.9% | 2.9% | ||
| Q1 25 | -10728.4% | -8.0% | ||
| Q4 24 | -19444.6% | 1.1% | ||
| Q3 24 | -9482.7% | 0.7% | ||
| Q2 24 | -11285.0% | -0.6% | ||
| Q1 24 | -23720.6% | -0.6% |
每股收益（稀释后）ACONRDNT
| Q4 25 | $1.39 | $0.00 | ||
| Q3 25 | $-2.93 | $0.07 | ||
| Q2 25 | $-2.75 | $0.19 | ||
| Q1 25 | $-9.32 | $-0.51 | ||
| Q4 24 | $-809.36 | $0.08 | ||
| Q3 24 | $-1321.49 | $0.04 | ||
| Q2 24 | $-1362.83 | $-0.04 | ||
| Q1 24 | $-3985.22 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $12.0M | $767.2M |
| 总债务越低越好 | — | $1.1B |
| 股东权益账面价值 | $12.8M | $1.1B |
| 总资产 | $13.7M | $3.8B |
| 负债/权益比越低杠杆越低 | — | 1.00× |
8季度趋势，按日历期对齐
现金及短期投资ACONRDNT
| Q4 25 | $12.0M | $767.2M | ||
| Q3 25 | $11.3M | $804.7M | ||
| Q2 25 | $12.8M | $833.2M | ||
| Q1 25 | $14.8M | $717.3M | ||
| Q4 24 | $453.7K | $740.0M | ||
| Q3 24 | $1.3M | $748.9M | ||
| Q2 24 | $1.2M | $741.7M | ||
| Q1 24 | $2.1M | $527.0M |
总债务ACONRDNT
| Q4 25 | — | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $1.0B | ||
| Q3 24 | — | $1.0B | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $834.6M |
股东权益ACONRDNT
| Q4 25 | $12.8M | $1.1B | ||
| Q3 25 | $12.5M | $1.1B | ||
| Q2 25 | $14.2M | $932.3M | ||
| Q1 25 | $15.8M | $898.1M | ||
| Q4 24 | $970.1K | $902.3M | ||
| Q3 24 | $2.5M | $895.3M | ||
| Q2 24 | $1.6M | $881.0M | ||
| Q1 24 | $2.5M | $873.0M |
总资产ACONRDNT
| Q4 25 | $13.7M | $3.8B | ||
| Q3 25 | $13.2M | $3.7B | ||
| Q2 25 | $14.8M | $3.5B | ||
| Q1 25 | $16.5M | $3.3B | ||
| Q4 24 | $2.1M | $3.3B | ||
| Q3 24 | $3.2M | $3.3B | ||
| Q2 24 | $3.1M | $3.2B | ||
| Q1 24 | $3.7M | $3.0B |
负债/权益比ACONRDNT
| Q4 25 | — | 1.00× | ||
| Q3 25 | — | 1.04× | ||
| Q2 25 | — | 1.18× | ||
| Q1 25 | — | 1.12× | ||
| Q4 24 | — | 1.13× | ||
| Q3 24 | — | 1.14× | ||
| Q2 24 | — | 1.17× | ||
| Q1 24 | — | 0.96× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.6M | $84.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ACONRDNT
| Q4 25 | $-1.6M | $84.2M | ||
| Q3 25 | $-1.2M | $52.8M | ||
| Q2 25 | $-1.9M | $120.3M | ||
| Q1 25 | $-2.5M | $41.5M | ||
| Q4 24 | $-922.9K | $42.5M | ||
| Q3 24 | $-1.1M | $57.4M | ||
| Q2 24 | $-1.1M | $116.0M | ||
| Q1 24 | $-2.2M | $17.1M |
自由现金流ACONRDNT
| Q4 25 | — | — | ||
| Q3 25 | $-1.2M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
自由现金流率ACONRDNT
| Q4 25 | — | — | ||
| Q3 25 | -6164.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资本支出强度ACONRDNT
| Q4 25 | — | — | ||
| Q3 25 | 38.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金转化率ACONRDNT
| Q4 25 | — | — | ||
| Q3 25 | — | 9.75× | ||
| Q2 25 | — | 8.33× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 7.96× | ||
| Q3 24 | — | 17.89× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ACON
暂无分部数据
RDNT
| Commercial Insurance1 | $301.0M | 55% |
| Medicare1 | $129.2M | 24% |
| Capitation Arrangements | $31.9M | 6% |
| Health Care Other | $20.4M | 4% |
| Digital Health | $16.4M | 3% |
| Other | $15.2M | 3% |
| Medicaid1 | $14.0M | 3% |
| Workers Compensation Personal Injury1 | $12.3M | 2% |
| Health Care Management Service | $7.5M | 1% |
